DK2964215T3 - Blanding af fedtsyrer til anvendelse i behandlingen af inflammatoriske patologier - Google Patents

Blanding af fedtsyrer til anvendelse i behandlingen af inflammatoriske patologier Download PDF

Info

Publication number
DK2964215T3
DK2964215T3 DK14708015T DK14708015T DK2964215T3 DK 2964215 T3 DK2964215 T3 DK 2964215T3 DK 14708015 T DK14708015 T DK 14708015T DK 14708015 T DK14708015 T DK 14708015T DK 2964215 T3 DK2964215 T3 DK 2964215T3
Authority
DK
Denmark
Prior art keywords
mixture
treatment
fat acids
inflammatory pathologies
pathologies
Prior art date
Application number
DK14708015T
Other languages
English (en)
Inventor
Lodovico Burattin
Original Assignee
Again Life Italia Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=48227394&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK2964215(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Again Life Italia Srl filed Critical Again Life Italia Srl
Application granted granted Critical
Publication of DK2964215T3 publication Critical patent/DK2964215T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/20Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/20Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/201Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/20Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Fats And Perfumes (AREA)
DK14708015T 2013-03-08 2014-03-04 Blanding af fedtsyrer til anvendelse i behandlingen af inflammatoriske patologier DK2964215T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361774796P 2013-03-08 2013-03-08
IT000354A ITMI20130354A1 (it) 2013-03-08 2013-03-08 Miscela di acidi grassi (f.a.g. fatty acids group) per uso nel trattamento di patologie infiammatorie.
PCT/EP2014/054163 WO2014135529A1 (en) 2013-03-08 2014-03-04 Mixture of fatty acids for use in the treatment of inflammatory pathologies

Publications (1)

Publication Number Publication Date
DK2964215T3 true DK2964215T3 (da) 2019-11-11

Family

ID=48227394

Family Applications (2)

Application Number Title Priority Date Filing Date
DK17169929.1T DK3219316T3 (da) 2013-03-08 2014-03-04 Blanding af fedtsyrer (f.a.g., fedtsyregruppe) til anvendelse i behandlingen af inflammatoriske patologier
DK14708015T DK2964215T3 (da) 2013-03-08 2014-03-04 Blanding af fedtsyrer til anvendelse i behandlingen af inflammatoriske patologier

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK17169929.1T DK3219316T3 (da) 2013-03-08 2014-03-04 Blanding af fedtsyrer (f.a.g., fedtsyregruppe) til anvendelse i behandlingen af inflammatoriske patologier

Country Status (18)

Country Link
US (2) US11020365B2 (da)
EP (2) EP2964215B1 (da)
AU (2) AU2014224710B2 (da)
CA (1) CA2904112C (da)
CY (2) CY1122248T1 (da)
DK (2) DK3219316T3 (da)
EA (2) EA035091B1 (da)
ES (2) ES2779851T3 (da)
HR (2) HRP20191963T1 (da)
HU (2) HUE046239T2 (da)
IT (1) ITMI20130354A1 (da)
LT (2) LT2964215T (da)
PL (2) PL2964215T3 (da)
PT (2) PT3219316T (da)
RS (2) RS60023B1 (da)
SI (2) SI3219316T1 (da)
SM (2) SMT202000115T1 (da)
WO (1) WO2014135529A1 (da)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20130354A1 (it) * 2013-03-08 2014-09-09 Again Life Italia Srl Miscela di acidi grassi (f.a.g. fatty acids group) per uso nel trattamento di patologie infiammatorie.
JP7118642B2 (ja) * 2014-08-08 2022-08-16 アリ リサーチ ソシエタ ア レスポンサビリタ リミタータ センプリフィカタ 炎症性およびアレルギー性病変の治療に用いるための脂肪酸とパルミトイルエタノールアミドの混合物
AR102008A1 (es) * 2015-09-24 2017-01-25 Brix S R L Ingrediente farmacéutico activo (ifa) oleoso para el tratamiento de afecciones de la piel, composiciones que lo comprenden y su uso para prepararlas
US20210205253A1 (en) * 2018-05-31 2021-07-08 The Asan Foundation Use Of Stearic Acid For Preventing Or Treating Pulmonary Fibrosis
EP3586641A1 (en) 2018-06-21 2020-01-01 Nuseed Pty Ltd Dha enriched polyunsaturated fatty acid compositions
EP3586643A1 (en) 2018-06-21 2020-01-01 Nuseed Pty Ltd Dha enriched polyunsaturated fatty acid compositions
KR102204097B1 (ko) * 2019-01-31 2021-01-18 동신대학교 산학협력단 지방산을 유효성분으로 포함하는 천식 예방 또는 치료용 조성물
CN116472023A (zh) * 2020-02-12 2023-07-21 拜奥吉瓦有限责任公司 用于化妆品应用的氘代多不饱和脂肪酸或其酯
AU2022328181A1 (en) 2021-08-09 2024-03-21 Kentucky Equine Research, Inc. Compositions and methods for modulating equine fatty acid profiles
US20240350447A1 (en) * 2021-11-24 2024-10-24 Jenivision Inc. Delivery methods for treating brain and central nervous system diseases
CN119385999A (zh) * 2024-11-06 2025-02-07 中国人民解放军军事科学院军事医学研究院 壬二酸在制备防治放射性肺损伤药物中的应用
CN120000629B (zh) * 2025-01-22 2025-12-05 华南师范大学 壬二酸在制备防治脓毒症急性肺损伤药物中的应用

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE155684T1 (de) * 1992-04-28 1997-08-15 Fresenius Ag Verwendung einer omega-3-fettsäuren enthaltenden emulsion zur herstellung eines parenteral zu verabreichenden arzneimittels zur behandlung von entzündlichen erkrankungen
UY24246A1 (es) 1995-06-06 1996-06-14 Neutrogena Corp Vehiculos tropicos que contienen acido azelaico solubilizado y estabilizado
EP1175901B1 (en) * 1999-04-15 2006-05-31 Kaneka Corporation Peroxisome activator-responsive receptor agonists
GB9923738D0 (en) 1999-10-07 1999-12-08 Nestle Sa Nutritional composition
DE10161729A1 (de) 2001-12-15 2003-06-18 Mira Ursic Medizinische bzw. pharmazeutische Salbenzubereitung
DE50211883D1 (de) 2002-04-30 2008-04-24 Cognis Ip Man Gmbh Verwendung von Wirkstoffmischungen mit Azelainsäure und Glycyrrhetinsäure als Anti-Aknemittel
WO2004084829A2 (en) * 2003-03-20 2004-10-07 Imagenetix, Inc. Esterified fatty acid composition
US20080057552A1 (en) * 2006-08-31 2008-03-06 Inmok Lee Processes for Producing Fats or Oils and Compositions Comprising the Fats or Oils
NZ552238A (en) 2006-12-20 2009-07-31 Seperex Nutritionals Ltd An extract
JP4512881B2 (ja) * 2007-11-27 2010-07-28 築 中島 薬用油脂
BRPI0909185A2 (pt) * 2008-03-20 2015-08-25 Virun Inc Derivado de vitamina e e seus usos
US20090264520A1 (en) 2008-04-21 2009-10-22 Asha Lipid Sciences, Inc. Lipid-containing compositions and methods of use thereof
JP6113954B2 (ja) * 2008-10-31 2017-04-12 リピッド ファーマシューティカルズ イーエイチエフ. 医薬として使用するための脂肪酸
DK2429317T4 (da) 2009-04-17 2019-05-13 Natac Pharma S L Sammensætninger med højt indhold af omega-3-fedtsyrer og med lavt indhold af phytansyre
ES2547133T5 (es) 2009-09-07 2019-02-15 Epitech Group S P A Composición que contiene palmitoiletanolamida ultramicronizada
CA2703532C (en) 2010-05-10 2018-05-01 Eva Turley Topically administered, skin-penetrating glycosaminoglycan formulations suitable for use in cosmetic and pharmaceutical applications
DE102010021671A1 (de) 2010-05-27 2011-12-01 Intendis Gmbh Azelainsäurehaltige Formulierung mit Pigmentzusatz
EP2661266B1 (en) 2011-01-07 2020-09-16 Anji Pharma (US) LLC Chemosensory receptor ligand-based therapies
US20120252888A1 (en) * 2011-03-29 2012-10-04 Palupa Medical Ltd. Compositions and Methods for Treating Neurologic Disorders
ITMI20130354A1 (it) * 2013-03-08 2014-09-09 Again Life Italia Srl Miscela di acidi grassi (f.a.g. fatty acids group) per uso nel trattamento di patologie infiammatorie.

Also Published As

Publication number Publication date
EP3219316A1 (en) 2017-09-20
EA035091B1 (ru) 2020-04-27
US20160015666A1 (en) 2016-01-21
CY1122783T1 (el) 2021-05-05
DK3219316T3 (da) 2020-03-16
SMT201900614T1 (it) 2020-01-14
PT3219316T (pt) 2020-03-27
WO2014135529A1 (en) 2014-09-12
LT3219316T (lt) 2020-04-10
EA201791885A1 (ru) 2018-01-31
AU2018202190B2 (en) 2019-05-02
CA2904112A1 (en) 2014-09-12
CA2904112C (en) 2021-03-23
US20210290578A1 (en) 2021-09-23
ITMI20130354A1 (it) 2014-09-09
ES2753257T3 (es) 2020-04-07
HUE046239T2 (hu) 2020-02-28
CY1122248T1 (el) 2020-11-25
AU2018202190A1 (en) 2018-04-26
EP2964215A1 (en) 2016-01-13
HK1243924A1 (en) 2018-07-27
HRP20191963T1 (hr) 2020-01-24
HUE048361T2 (hu) 2020-08-28
HRP20200394T1 (hr) 2020-06-12
PT2964215T (pt) 2019-11-12
PL3219316T3 (pl) 2020-06-01
SMT202000115T1 (it) 2020-05-08
AU2014224710B2 (en) 2018-04-12
RS59523B1 (sr) 2019-12-31
RS60023B1 (sr) 2020-04-30
EA201591680A1 (ru) 2015-12-30
PL2964215T3 (pl) 2020-03-31
LT2964215T (lt) 2019-11-25
SI3219316T1 (sl) 2020-07-31
EP2964215B1 (en) 2019-08-21
EA036724B1 (ru) 2020-12-11
ES2779851T3 (es) 2020-08-20
AU2014224710A1 (en) 2015-09-10
US11020365B2 (en) 2021-06-01
SI2964215T1 (sl) 2019-12-31
EP3219316B1 (en) 2020-02-19

Similar Documents

Publication Publication Date Title
CY2021007I1 (el) Συνθεσεις χρησιμες για τη θεραπεια διαταραχων που σχετιζονται με kit
DK2964215T3 (da) Blanding af fedtsyrer til anvendelse i behandlingen af inflammatoriske patologier
DK3811943T3 (da) Forbindelse til anvendelse til behandling af øjenlidelser
EP3763364C0 (en) SELF-EMULSIFYING OMEGA-3 FATTY ACID COMPOSITION
DK3054783T3 (da) Sammensætning af mellemkædede fedtsyrer og foder suppleret med samme
PL3466308T3 (pl) Miksery stojące
DK3021839T3 (da) Sammensætninger for behandling af fibrose
DK3010895T3 (da) Fremgangsmåde til fremstilling af 4-propargyleret aminobenzoxazinoner
DK3149049T3 (da) Il-22 til anvendelse til behandling af stofskiftesygdomme
DK3083683T3 (da) Sammensætninger og fremgangsmåder til behandling af fedtvævsansamlinger
DK3177281T3 (da) Blanding af fedtsyrer og palmitoylethanolamid til brug i behandlingen af betændelses og allergiske patologier
DK2956010T4 (da) Fedtsammensætning
HRP20181122T1 (hr) Postupak za pripremu jopamidola
DK3044229T3 (da) Peptider til anvendelse i behandlingen af oral mucositis
DK2886108T4 (da) Optimeret farmaceutisk formulering til behandling af inflammatoriske ændringer af øsofagus
PT3016654T (pt) Ácido tauroursodeoxicólico (tudca) para utilização no tratamento de doenças neurodegenerativas
ZA201507724B (en) The treatment of inflammatory disorders
EP2873719A4 (en) GREASE COMPOSITION
DK3041831T3 (da) Alfa-te-saltformer: sammensætninger og anvendelser til behandling af sygdom
FI20150044A7 (fi) Rasvahappokoostumus
DK3369435T3 (da) Sammensætning til behandling af inflammatorisk ledsygdom
HUE042691T2 (hu) Tiazolo-pirimidinon felhasználása gyulladásos bélbetegségek kezeléséhez
ES1079130Y (es) Camilla con aplicacion de masaje automatico
BR302013001555S1 (pt) Configuração aplicada em instrumento para assar peixe
ES1095430Y (es) Camilla para masajes